Table 4.
Neurologic | Endocrine | Vascular | Visual | |
---|---|---|---|---|
# Patients in study | ||||
1–10 | 9% | 2% | 1% | 6% |
11–20 | 2% | 7% | 0% | 2% |
21+ | 1% | 1% | 0% | 4% |
P < 0.001 | P < 0.01 | P = 0.12 | P = 0.45 | |
Patient age | ||||
0–2 | 9% | 48% | 0% | 4% |
2.1–5 | 5% | 41% | 0% | 0% |
5.1–10 | 5% | 44% | 1% | 2% |
11–20 | 5% | 34% | 0% | 2% |
21–50 | 5% | 37% | 1% | 4% |
51+ | 2% | 31% | 0% | 3% |
P = 0.84 | P = 0.41 | P = 0.85 | P = 0.73 | |
Tumor size | ||||
<3 cm | 0% | 36% | 0% | 6% |
≥3 cm | 10% | 43% | 2% | 0% |
P = 0.06 | P = 0.33 | P = 0.59 | P = 0.16 | |
Hypothalamic involvement | ||||
Minor or none | 5% | 40% | 5% | 3% |
Extensive | 5% | 33% | 5% | 5% |
P = 0.50 | P = 0.09 | P = 0.43 | P = 0.35 |